Back Hepatitis B Hepatitis B Topics HBV Prevention

HBV Prevention

CDC Advisory Committee Recommends Hepatitis B Vaccine for People with Diabetes

The Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) last week recommended that adults up to age 60 with diabetes should be vaccinated against hepatitis B virus (HBV), as this group has a higher risk of infection compared with the general population.alt

Read more:

ICAAC: Double Dose of Hepislav Works as Well as 3 Doses of Standard HBV Vaccine

Two injections of Dynavax's investigational Hepislav hepatitis B virus (HBV) vaccine protected adults over age 40 as well as the standard regimen consisting of 3 doses of the Engerix-B vaccine given over 6 months, researchers reported at the 51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2011) last month in Chicago.alt

Read more:

Hepatitis B Vaccination Dramatically Lowers Prevalence among U.S. Children

Children and adolescents in the U.S. today have a very low likelihood of hepatitis B virus (HBV) infection thanks to widespread vaccination, according to an epidemiological study described in the March 1, 2011, Annals of Internal Medicine. Many adults remain vulnerable, however, underlining the importance of vaccination for at-risk groups. alt

Read more:

Additional HBV Vaccine Dose Offers More Protection for People with HIV

Two alternative dosing schedules of hepatitis B virus (HBV) vaccination led to higher levels of protection than the standard 3-dose schedule. alt

Read more: